跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APREMILAST TARBIS 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APREMILAST TARBIS 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
APREMILAST TARBIS 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Tarbis Farma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 12, 2024
Approval ID
59f21cc931afc412
Company
Tarbis Farma S.L.
Type
Standard
Approval Details
Approval Id
59f21cc931afc412
Drug Cima Aemps Name
APREMILAST TARBIS 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89939
Holder Company Name
Tarbis Farma S.L.
Marketing Company Name
Tarbis Farma S.L.
Authorization Date
2024-11-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg + 20 mg + 30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Tarbis Farma S.L.
Active Ingredients
APREMILAST
30 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 12, 2024
Approval ID
59f21cc931afc412
Type
Standard
Back to CIMA-AEMPS Approvals